Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
Afon Technology is revolutionising diabetes care with its innovative GlucowearTM – the world’s first non-invasive, real-time continuous glucose monitor. Company CEO, Sabih Chaudhry, explains how the technology is being recognised and developed.
In this article, our thoughts are directed towards understanding the Canadian Institutions of Health Research (CIHR) and The Institute of Nutrition, Metabolism and Diabetes (INMD).
Here, Dr Albert A. de Graaf discusses a novel predictive model-based decision support system to aid diabetes patients in the complex task of self-management.
As part of World Glaucoma Week, Alastair Lockwood, ophthalmologist and eye health specialist at Feel Good Contacts, explains how to minimise the risks of developing glaucoma in later life, and for lens wearers, how to ensure you are wearing them most effectively.
Emma Elvin, Senior Clinical Advisor at Diabetes UK, highlights a relentless and unsustainable rise in emergency hospital admissions in the UK’s NHS and the impact of this on those with diabetes.
The University of Salford’s Diabetes Care education programmes are designed to address and meet the need for specialist care in the UK and internationally.
The Global Food Research Program shares their perspective on targeting ultra-processed foods with front-of-the-package warning labels, which is the only impactful approach.
Tammy Z Movsas, MD, MPH, discusses how the Zietchick Research Institute aims to identify the main stimulus for the rapid progression of diabetic retinopathy during pregnancy.
The role of vitamin D in pregnancy, preeclampsia and pregnancy loss are examined here as an example of the excellent work of the Eunice Kennedy Shriver National Institute of Child Health and Human Development in the U.S. around investigating human development.
The role of vitamin D in pregnancy is an example of work by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, investigating human development.
The cardiovascular side effects of night-time train noise is placed under the spotlight here by a group of experts from Gutenberg-University Mainz in Germany and the Danish Cancer Society.
Emily Y. Chew, M.D., Director of the Division of Epidemiology and Clinical Applications and the Deputy Clinical Director at the National Eye Institute, part of the National Institutes of Health, examines why early detection is crucial to prevent blindness from diabetic retinopathy.
Lalit Singh Pukhrambam, PhD, and Ahmed S Ibrahim, PhD from Wayne State University School of Medicine in the U.S. focus here on the importance of combating diabetic retinopathy.
The Global Food Research Program, University of North Carolina in the U.S. share their perspective on how taxes on sugary beverages are important components of noncommunicable disease and obesity prevention strategies.
Here, OilsBySimpson Founder Kevin Simpson and Clinical Professor, Consultant Physician and Research Director, Filip Krag Knop, explain what we know so far about CBD’s effect on Type 2 diabetes and why running a clinical trial is so important.
